Skip to main content
SpringerLink
Log in

Primary Central Nervous System and Retinal Lymphoma

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology

  • 941 Accesses

Abstract

Primary lymphoma of the central nervous system (CNS) is considered a variant of extra-nodal non-Hodgkin’s lymphoma (NHL), a high-grade B-cell malignancy associated with a median survival ranging from one to 8 years depending on factors such as age and Karnofsky performance status [1]. Primary CNS lymphoma (PCNSL) originates in the brain parenchyma, spinal cord, leptomeninges, and eyes [2]. Formerly used descriptors such as “reticulum cell sarcoma” and “microgliomatosis” are no longer preferred as both misleadingly imply that the lymphoma arises from transformed reticulum or microglial cells. Primary intraocular lymphoma (PCNSL-O) is a variant of PCNSL with predominantly ophthalmic involvement. As vitreoretinal manifestations are the dominant feature, the term primary vitreoretinal lymphoma (PVRL) is commonly used. In contrast, other forms of ocular lymphoma typically affect the adnexal structures or uveal tract. The distinction is important as uveal and ocular adnexal lymphoma are usually low-grade, indolent, B-cell lymphomas that behave similarly to extra-nodal marginal zone lymphoma(EMZL) found elsewhere in the body [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abrey LE, Ben-Porat L, Panageas KS, et al. Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol. 2006;24(36):5711–5.

    Article  PubMed  Google Scholar 

  2. Pe’er J, Hochberg FH, Foster CS. Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm. 2009;17(5):299–306.

    Article  PubMed  Google Scholar 

  3. Bardenstein D. Orbital and adnexal lymphoma. In: Singh AD, Damato BE, Pe’er J, et al., editors. Clinical ophthalmic oncology. Philadelphia: Saunders-Elsevier; 2007.

    Google Scholar 

  4. DeAngelis LM. Primary central nervous system lymphoma. Curr Opin Neurol. 1999;12(6):687–91.

    Article  PubMed  CAS  Google Scholar 

  5. Singh AD, Lewis H, Schachat AP. Primary lymphoma of the central nervous system. Ophthalmol Clin North Am. 2005;18(1):199–207, x.

    Article  PubMed  Google Scholar 

  6. Newell ME, Hoy JF, Cooper SG, et al. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer. 2004;100(12):2627–36.

    Article  PubMed  Google Scholar 

  7. Stanton CA, Sloan 3rd B, Slusher MM, Greven CM. Acquired immunodeficiency syndrome-related primary intraocular lymphoma. Arch Ophthalmol. 1992;110(11):1614–7.

    Article  PubMed  CAS  Google Scholar 

  8. Mittra RA, Pulido JS, Hanson GA, et al. Primary ocular Epstein-Barr virus-associated non-Hodgkin’s lymphoma in a patient with AIDS: a clinicopathologic report. Retina. 1999;19(1):45–50.

    Article  PubMed  CAS  Google Scholar 

  9. Marshall AG, Pawson R, Thom M, et al. HTLV-I associated primary CNS T-cell lymphoma. J Neurol Sci. 1998;158(2):226–31.

    Article  PubMed  CAS  Google Scholar 

  10. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg. 1988;68(6):835–53.

    Article  PubMed  CAS  Google Scholar 

  11. Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol. 2003;241(10):860–70.

    Article  PubMed  Google Scholar 

  12. Choi JS, Nam DH, Ko YH, et al. Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas. Am J Surg Pathol. 2003;27(7):919–28.

    Article  PubMed  Google Scholar 

  13. Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer. 2002;95(7):1504–10.

    Article  PubMed  Google Scholar 

  14. Ahluwalia MS, Peereboom DM. Primary central nervous system lymphoma. Curr Treat Options Neurol. 2010;12(4):347–59.

    Article  PubMed  Google Scholar 

  15. Gerstner ER, Batchelor TT. Primary central nervous system lymphoma. Arch Neurol. 2010;67(3):291–7.

    Article  PubMed  Google Scholar 

  16. Diamond C, Taylor TH, Aboumrad T, Anton-Culver H. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer. 2006;106(1):128–35.

    Article  PubMed  CAS  Google Scholar 

  17. Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol. 2002;13(6):411–8.

    Article  PubMed  Google Scholar 

  18. Char DH, Ljung BM, Miller T, Phillips T. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology. 1988;95(5):625–30.

    PubMed  CAS  Google Scholar 

  19. Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology. 1993;100(9):1399–406.

    PubMed  CAS  Google Scholar 

  20. Babu K, Murthy KR, Krishnakumar S. Two successive ocular malignancies in the same eye of a HIV-positive patient: a case report. Ocul Immunol Inflamm. 2010;18(2):101–3.

    Article  PubMed  Google Scholar 

  21. Mathai A, Lall A, Jain R, Pathengay A. Systemic non-Hodgkin’s lymphoma masquerading as Vogt-Koyanagi-Harada disease in an HIV-positive patient. Clin Experiment Ophthalmol. 2006;34(3):280–2.

    Article  PubMed  Google Scholar 

  22. Rajagopal R, Harbour JW. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina. 2011;31(3):435–40.

    Article  PubMed  CAS  Google Scholar 

  23. Freeman LN, Schachat AP, Knox DL, et al. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology. 1987;94(12):1631–9.

    PubMed  CAS  Google Scholar 

  24. Peterson K, Gordon KB, Heinemann MH, DeAngelis LM. The clinical spectrum of ocular lymphoma. Cancer. 1993;72(3):843–9.

    Article  PubMed  CAS  Google Scholar 

  25. Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology. 1999;106(9):1805–10.

    Article  PubMed  CAS  Google Scholar 

  26. Gass JD, Sever RJ, Grizzard WS, et al. Multifocal pigment epithelial detachments by reticulum cell sarcoma. A characteristic funduscopic picture. Retina. 1984;4(3):135–43.

    Article  PubMed  CAS  Google Scholar 

  27. Gass JD, Trattler HL. Retinal artery obstruction and atheromas associated with non-Hodgkin’s large cell lymphoma (reticulum cell sarcoma). Arch Ophthalmol. 1991;109(8):1134–9.

    Article  PubMed  CAS  Google Scholar 

  28. Michelson JB, Michelson PE, Bordin GM, Chisari FV. Ocular reticulum cell sarcoma. Presentation as retinal detachment with demonstration of monoclonal immunoglobulin light chains on the vitreous cells. Arch Ophthalmol. 1981;99(8):1409–11.

    Article  PubMed  CAS  Google Scholar 

  29. Lang GK, Surer JL, Green WR, et al. Ocular reticulum cell sarcoma. Clinicopathologic correlation of a case with multifocal lesions. Retina. 1985;5(2):79–86.

    Article  PubMed  CAS  Google Scholar 

  30. Purvin V, Van Dyk HJ. Primary reticulum cell sarcoma of the brain presenting as steroid-responsive optic neuropathy. J Clin Neuroophthalmol. 1984;4(1):15–23.

    Article  PubMed  CAS  Google Scholar 

  31. Margolis R, Brasil OF, Lowder CY, et al. Vitrectomy for the diagnosis and management of uveitis of unknown cause. Ophthalmology. 2007;114(10):1893–7.

    Article  PubMed  Google Scholar 

  32. Yeh S, Weichel ED, Faia LJ, et al. 25-Gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma. Br J Ophthalmol. 2010;94(5):633–8.

    Article  PubMed  Google Scholar 

  33. Rishi K, Font RL, Chevez-Barrios P. Diagnostic yield of liquid-based cytology, immunophenotyping and molecular techniques in lymphomas and other entities in vitrectomy specimens. Invest Ophthalmol Vis Sci. 2004;45:1072.

    Google Scholar 

  34. Coupland SE. Vitreous biopsy: specimen preparation and interpretation. Monogr Clin Cytol. 2012;21:61–71.

    Article  PubMed  Google Scholar 

  35. Bechrakis NE, Foerster MH, Bornfeld N. Biopsy in indeterminate intraocular tumors. Ophthalmology. 2002;109(2):235–42.

    Article  PubMed  Google Scholar 

  36. Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology. 2008;71(17):1355–60.

    Article  PubMed  CAS  Google Scholar 

  37. Farkas T, Harbour JW, Davila RM. Cytologic diagnosis of intraocular lymphoma in vitreous aspirates. Acta Cytol. 2004;48(4):487–91.

    Article  PubMed  Google Scholar 

  38. Kim EW, Zakov ZN, Albert DM, et al. Intraocular reticulum cell sarcoma: a case report and literature review. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1979;209(3):167–78.

    PubMed  CAS  Google Scholar 

  39. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995;120(5):671–3.

    PubMed  CAS  Google Scholar 

  40. Buggage RR, Whitcup SM, Nussenblatt RB, Chan CC. Using interleukin 10 to interleukin 6 ratio to distinguish primary intraocular lymphoma and uveitis. Invest Ophthalmol Vis Sci. 1999;40(10):2462–3.

    PubMed  CAS  Google Scholar 

  41. Akpek EK, Foster CS. Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogeneous IgH gene arrangement. Arch Ophthalmol. 2000;118(5):731–2.

    CAS  Google Scholar 

  42. Shen DF, Zhuang Z, LeHoang P, et al. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology. 1998;105(9):1664–9.

    Article  PubMed  CAS  Google Scholar 

  43. White VA, Gascoyne RD, Paton KE. Use of the polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma. Arch Ophthalmol. 1999;117(6):761–5.

    Article  PubMed  CAS  Google Scholar 

  44. Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull Johns Hopkins Hosp. 1907;18:382–91.

    CAS  Google Scholar 

  45. Comer GM, Brandt LJ, Abissi CJ. Whipple’s disease: a review. Am J Gastroenterol. 1983;78(2):107–14.

    PubMed  CAS  Google Scholar 

  46. Moortgat I, Van Ginderdeuren R, Van Calster J. Familial vitreous amyloidosis linked with factor V Leiden deficiency. Br J Ophthalmol. 2011;95(12):1755, 62.

    Article  PubMed  CAS  Google Scholar 

  47. Ciulla TA, Tolentino F, Morrow JF, Dryja TP. Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation. Surv Ophthalmol. 1995;40(3):197–206.

    Article  PubMed  CAS  Google Scholar 

  48. Gregory ME, Carey M, Hawkins PN, et al. Characterisation and management of vitreous and nerve amyloid in familial amyloid polyneuropathy due to variant transthyretin, Phe33Val. Br J Ophthalmol. 2008;92(1):34–5, 142.

    Article  PubMed  Google Scholar 

  49. Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol. 1995;40(3):173–96.

    Article  PubMed  CAS  Google Scholar 

  50. Agarwal A, Colburn JD, Raja H, Singh AD. Diagnostic and therapeutic challenges. Retina. 2012;32(8):1678–81.

    Article  PubMed  Google Scholar 

  51. Levy-Clarke GA, Buggage RR, Shen D, et al. Human T-cell lymphotropic virus type-1 associated t-cell leukemia/lymphoma masquerading as necrotizing retinal vasculitis. Ophthalmology. 2002;109(9):1717–22.

    Article  PubMed  Google Scholar 

  52. Bhat PV, Jakobiec FA, Papaliodis G, Sobrin L. Primary T-cell lymphoma of the retina and cerebellum: immunophenotypic and gene rearrangement confirmation. Am J Ophthalmol. 2009;148(3):350–60.

    Article  PubMed  CAS  Google Scholar 

  53. Schanzer MC, Font RL, O’Malley RE. Primary ocular malignant lymphoma associated with the acquired immune deficiency syndrome. Ophthalmology. 1991;98(1):88–91.

    PubMed  CAS  Google Scholar 

  54. Margolis L, Fraser R, Lichter A, Char DH. The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer. 1980;45(4):688–92.

    Article  PubMed  CAS  Google Scholar 

  55. Smith JR, Rosenbaum JT, Wilson DJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology. 2002;109(9):1709–16.

    Article  PubMed  Google Scholar 

  56. Frenkel S, Hendler K, Siegal T, et al. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol. 2008;92(3):383–8.

    Article  PubMed  CAS  Google Scholar 

  57. Itty S, Pulido JS. Rituximab for intraocular lymphoma. Retina. 2009;29(2):129–32.

    Article  PubMed  Google Scholar 

  58. Batchelor TT, Kolak G, Ciordia R, et al. High-dose methotrexate for intraocular lymphoma. Clin Cancer Res. 2003;9(2):711–5.

    PubMed  CAS  Google Scholar 

  59. Abrey LE, Moskowitz CH, Mason WP, et al. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis. J Clin Oncol. 2003;21(22):4151–6.

    Article  PubMed  CAS  Google Scholar 

  60. Soussain C, Hoang-Xuan K, Taillandier L, et al. Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Societe Francaise de Greffe de Moelle Osseuse-Therapie Cellulaire. J Clin Oncol. 2008;26(15):2512–8.

    Article  PubMed  Google Scholar 

  61. Soussain C, Suzan F, Hoang-Xuan K, et al. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol. 2001;19(3):742–9.

    PubMed  CAS  Google Scholar 

  62. Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol. 2007;18(11):1851–5.

    Article  PubMed  CAS  Google Scholar 

  63. Deangelis LM, Hormigo A. Treatment of primary central nervous system lymphoma. Semin Oncol. 2004;31(5):684–92.

    Article  PubMed  Google Scholar 

  64. Correa DD, DeAngelis LM, Shi W, et al. Cognitive functions in survivors of primary central nervous system lymphoma. Neurology. 2004;62(4):548–55.

    Article  PubMed  CAS  Google Scholar 

  65. Angelov L, Doolittle ND, Kraemer DF, et al. Blood–brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. J Clin Oncol. 2009;27(21):3503–9.

    Article  PubMed  CAS  Google Scholar 

  66. Galor A, Ference SJ, Singh AD, et al. Maculopathy as a complication of blood–brain barrier disruption in patients with central nervous system lymphoma. Am J Ophthalmol. 2007;144(1):45–9.

    Article  PubMed  Google Scholar 

  67. http://clinicaltrials.gov/show/NCT01399372

  68. Blay JY, Conroy T, Chevreau C, et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol. 1998;16(3):864–71.

    PubMed  CAS  Google Scholar 

  69. Ferreri AJ, Blay JY, Reni M, et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol. 2003;21(2):266–72.

    Article  PubMed  Google Scholar 

  70. Chang CC, Kampalath B, Schultz C, et al. Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals. Arch Pathol Lab Med. 2003;127(2):208–12.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuro-Oncology Outcomes, The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA

    Manmeet S. Ahluwalia MD, FACP

  2. Neuro Oncology Fellow, The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA

    Saurabh Dahiya MD

  3. Department of Ophthalmic Oncology, Cole Eye Institute (i32), Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Mary E. Aronow MD & Arun D. Singh MD

  4. The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA

    David Peereboom MD

Authors
  1. Manmeet S. Ahluwalia MD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saurabh Dahiya MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary E. Aronow MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Peereboom MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Arun D. Singh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mary E. Aronow MD .

Editor information

Editors and Affiliations

  1. Dept. of Ophthalmic Oncology, Cole Eye Institute Cleveland Clinic Foundation, Cleveland, Ohio, USA

    Arun D. Singh

  2. Ocular Oncology Service, Dept of Ophthalmology, University of California, San Francisco, California, USA

    Bertil Damato

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ahluwalia, M.S., Dahiya, S., Aronow, M.E., Peereboom, D., Singh, A.D. (2014). Primary Central Nervous System and Retinal Lymphoma. In: Singh, A., Damato, B. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39489-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-39489-8_7

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-39488-1

  • Online ISBN: 978-3-642-39489-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation